Developing
Therapies For
Neurodegeneration

Leading Innovation in Neurodegenerative Disease Therapies

About Us

Annovis is a pioneering company in the field of neurodegenerative disease research, focusing on developing transformative therapies for disorders such as Alzheimer's Disease (AD) and Parkinson's Disease (PD). Our goal is to develop effective treatments for some of the most challenging neurological conditions by restoring nerve cell function and improving cognitive and motor abilities in patients.

We attack neurodegeneration by enhancing the flow of information

Alzheimer’s Disease

Our Alzheimer’s program is dedicated to creating treatments that restore cognitive functions in patients at all stages of disease.

Learn More

Parkinson's Disease

Our Parkinson's program focuses on developing therapies that improve motor function and slow disease progression.

Learn More

Other Disorders

Our research extends beyond Alzheimer's and Parkinson’s, addressing multiple neurodegenerative disorders.

Learn More

Our Pipeline

Growing Challenge

Alzheimer’s Disease

6.9M

Americans living with Alzheimer's

2X

Americans will be diagnosed by 2060

2%

Success rate of developing new
treatments for Alzheimer's

Parkinson's Disease

1M

Americans living with Parkinson's

1.2M

Americans will be diagnosed by 2030

14.9%

Success rate of clinical trials
for Parkinson's

Stay Updated with Annovis Bio, Inc.
(NYSE: ANVS)

Join the Annovis Bio Newsletter to receive the latest updates on our groundbreaking research and developments in neurodegenerative diseases like Alzheimer's and Parkinson's